Multifunctional Nanoparticles for Dual Drug Release
A special issue of Materials (ISSN 1996-1944). This special issue belongs to the section "Biomaterials".
Deadline for manuscript submissions: closed (31 December 2020) | Viewed by 339
Special Issue Editor
Interests: pyrrole macrocycles for imaging and theranostics; nanoparticles for sensing applications and drug delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Combination therapies have long been adopted as strategies to overcome drug resistance. The general principle of combination therapy is the administration of more than one drug, with an independent mechanism of action, with the aim to enhance the efficiency of the treatment. The concept of combination therapy was first introduced in the treatment of tuberculosis to reduce the risk of resistance. However, it was not until the 1960s that this approach was proposed for the fight against cancer chemoresistance. For an optimal performance, the implementation of such therapies requires the delivery of the correct combination of drugs to a specific cellular target, which minimize undesirable side-effects. In this context, the use of nanoparticles (NPs) as platforms for the co-delivery of multiple drugs have emerged as a promising strategy. A wide range of nanoparticles has been proposed to design these delivery systems, such as metallic NPs, polymeric NPs and carbon NPs. A recent example of a dual drug release system in the treatment of microbial infections, is the combination of silver nanoparticles with antibiotics. In the area of cancer, the very promising combination of antitumoral small molecules with the highly sensitive siRNA should be highlighted. Unfortunately, despite the encouraging progress accomplished, there are still many practical aspects about the design, performance, safety and scalability of the nano-vehicles that need to be addressed in order to bring the concept into practice in the clinic. Hence, with the aim to foster innovative research in this field and share novel ideas, we invite you to contribute your research article, communication or review for this Special Issue.
Dr. David Sánchez-García
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Materials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Nanoparticles
- Drug delivery
- Combination therapy
- Chemoresistance
